Harmony Biosciences Holdings Inc (HRMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 201,267 | 186,038 | 172,814 | 154,615 | 168,412 |
| Cost of Goods | 54,409 | 42,778 | 32,144 | 27,484 | 43,152 |
| Gross Profit | 146,858 | 143,260 | 140,670 | 127,131 | 125,260 |
| Operating Expenses | 91,540 | 82,328 | 119,458 | 75,582 | 85,216 |
| Operating Income | 55,727 | 61,710 | 21,356 | 52,033 | 40,196 |
| Interest Expense | 4,209 | 4,348 | 4,404 | 4,535 | 4,796 |
| Other Income | 4,637 | 4,808 | 4,742 | 4,287 | 4,289 |
| Pre-tax Income | 56,155 | 62,170 | 21,694 | 51,785 | 39,689 |
| Income Tax | 6,680 | 16,077 | 10,103 | 13,451 | 13,082 |
| Net Income Continuous | 49,475 | 46,093 | 11,591 | 38,334 | 26,607 |
| Net Income | $49,475 | $46,093 | $11,591 | $38,334 | $26,607 |
| EPS Basic Total Ops | 0.87 | 0.81 | 0.20 | 0.68 | 0.47 |
| EPS Basic Continuous Ops | 0.87 | 0.81 | 0.20 | 0.68 | 0.46 |
| EPS Diluted Total Ops | 0.85 | 0.79 | 0.20 | 0.67 | 0.46 |
| EPS Diluted Continuous Ops | 0.85 | 0.79 | 0.20 | 0.67 | 0.45 |
| EPS Diluted Before Non-Recurring Items | 0.85 | 0.79 | 0.20 | N/A | N/A |
| EBITDA(a) | $61,373 | $67,303 | $26,958 | $57,743 | $45,822 |